RHONDA STRUNK: Open Payments
NPI 1659374940 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 10 payments from 8 companies in 2025. Trend: 2023 $1,543 · 2024 $2,311 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $248 |
| GENZYME CORPORATION | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $118 |
| UCB, Inc. | 1 | $78 |
| PFIZER INC. | 1 | $77 |
| LEO Pharma Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $15 |
Products named: Opzelura, DUPIXENT, INGREZZA, Bimzelx, LITFULO, ADBRY, ILUMYA.
Industry payments across NV — which companies pay providers there.
